TGen News & Press Releases : Muscular Dystrophy Association Funds Large-Scale Gene Screening Project to Find ALS Clues
Main Image

Evening of Trends 2018 fundraising gala benefits TGen

Trends Magazine charity aligns with TGen focus on women and children

PARADISE VALLEY, Ariz. — Sept. 5, 2018 — “BE BOLD, Be Beautiful” is the theme of Evening of Trends 2018, a fundraising gala presented by Trends Magazine and its Trends Charitable Fund in support of the Translational Genomics Research Institute (TGen).

The gala starts at 6 p.m. Saturday, Oct. 13, at the Omni Scottsdale Resort & Spa at Montelucia, 4949 E. Lincoln Drive. 

This year, the Trends Charitable Fund board selected TGen as its beneficiary because of the institute’s innovative genomic technologies and focus on women and children. Phoenix-based TGen is a global leader in precision medicine, a rapidly evolving field transforming the diagnosis, treatment and prevention of cancer and other life-threatening diseases.

“The mission of Trends Charitable Fund is to support programs that positively impact women, children and their families,” said Vicki Vaughn, Chair of Evening of Trends 2018. “TGen is a perfect fit for our mission through its Ovarian Cancer Research and its Center for Rare Childhood Disorders.”

Since it was establish in 1986, Trends Charitable Fund has granted more than $5 million to charities benefiting Arizona women, children and families.

Among the 2018 Trendsetters designated by the magazine, Trends selected Sue Glawe as its 2018 Fabulous Phoenician. Glawe is Vice President of Community Relations for Blue Cross Blue Shield of Arizona, and a long-time supporter of TGen.

“With the breakthroughs TGen is achieving in the care and treatment of women with cancer and children with rare neurological disorders, I can’t think of a more deserving non-profit entity to be recognized this year by Trends,” said Glawe, who has served on numerous Arizona boards, including Florence Crittenton, Southwest Autism Research & Resource Center, and the Arizona Educational Foundation.

Dr. Jeffrey Trent, TGen President and Research Director, praised Glawe for her nearly two decades of efforts supporting TGen: “Sue Glawe brings an abundance of energy and promotes success in every community effort she touches. Since our inception back in 2002, she has always been in our corner. We thank her for all that she has done to encourage our science and bring substantial benefit to our patients.”

Other 2018 Trendsetters are: Nikki Balich Cammarata, Leslie Budinger, Sharon Dupont McCord, Ingrid Haas, Sharon Lechter, Cionne McCarthy, Camerone Parker McCulloch, Kim Zieser, McKenna Wesley and Sylvia Shoen.

“We are so grateful to all those associated with Trends Magazine, the Trends Charitable Fund and Evening of Trends 2018 for selecting TGen as this year’s beneficiary,” said Erin Massey, Chief Development Officer of the TGen Foundation. “TGen’s dedicated faculty and staff will put these dollars to work immediately to benefit women and children patients and the families we serve.”

Tickets for the Oct. 13 event range from $500 for individuals to $25,000 for a “Be Valiant, Be Victorious” table for 10. For more information or to donate to the Trends Charitable Fund, visit: www.trendscharitablefund.org.

# # #

About Trends Magazine
Trends Magazine focuses on Arizona society, fashion, home, dining and art. It is published seven times a year, from November to May, at the end of each of those months. For more information, contact publisher Bill Dougherty at [email protected] or 480-990-9007.

About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is affiliated with City of Hope, a world-renowned independent research and cancer and diabetes treatment center: www.cityofhope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes, and infectious diseases, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org. Follow TGen on FacebookLinkedIn and Twitter @TGen.

Media Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]


Search



Media Contact



RSS Feed

Newsletter